• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过计算机辅助分析预测杨梅素通过抑制VEGFR2信号通路抑制血管生成。

Prediction of angiogenesis suppression by myricetin from via inhibiting VEGFR2 signaling pathway using computer-aided analysis.

作者信息

Bhuiyan Marjanur Rahman, Ahmed Khondoker Shahin, Reza Md Sharif, Hossain Hemayet, Siam Syed Mumtahin Mannan, Nayan Shahriar, Jafrin Sarah, Shuvo Sadikur Rahman, Ud Daula A F M Shahid

机构信息

Department of Pharmacy, Noakhali Science and Technology University, Sonapur, Noakhali, 3814, Bangladesh.

Chemical Research Division, Bangladesh Council of Scientific and Industrial Research (BCSIR), Dhaka, 1205, Bangladesh.

出版信息

Heliyon. 2025 Jan 7;11(2):e41749. doi: 10.1016/j.heliyon.2025.e41749. eCollection 2025 Jan 30.

DOI:10.1016/j.heliyon.2025.e41749
PMID:39897831
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11786634/
Abstract

Vascular endothelial growth factor receptor-2 (VEGFR2) plays a pivotal role in promoting angiogenesis and contributing to the growth and progression of renal cancer. Hence, the current investigation was undertaken with the aim of identifying safe and potent phytochemicals from whole plant extract (AiWE) that can efficiently suppress the overexpression of VEGFR2. HPLC analysis identified and quantified 11 polyphenols in considerable amounts in AiWE. All the compounds showed good binding energies with VEGFR2 in the molecular docking study, except catechin hydrate and rutin hydrate. However, among the polyphenols, myricetin exhibited an almost similar hydrogen bonding pattern with the active site of VEGFR2. The all-atom molecular dynamic simulation revealed that myricetin showed a very stable interaction with the active site of VEGFR2 throughout the simulation. Based on these results, it is suggested that myricetin may inhibit angiogenesis by suppressing the VEGFR2 signaling, thereby impeding the growth and progression of renal cancer.

摘要

血管内皮生长因子受体-2(VEGFR2)在促进血管生成以及推动肾癌的生长和进展过程中发挥着关键作用。因此,本次研究旨在从全株提取物(AiWE)中鉴定出安全且有效的植物化学物质,这些物质能够有效抑制VEGFR2的过表达。高效液相色谱分析鉴定并定量了AiWE中含量可观的11种多酚类物质。在分子对接研究中,除了儿茶素水合物和芦丁水合物外,所有化合物与VEGFR2均表现出良好的结合能。然而,在这些多酚类物质中,杨梅素与VEGFR2的活性位点呈现出几乎相似的氢键模式。全原子分子动力学模拟显示,在整个模拟过程中,杨梅素与VEGFR2的活性位点表现出非常稳定的相互作用。基于这些结果,表明杨梅素可能通过抑制VEGFR2信号传导来抑制血管生成,从而阻碍肾癌的生长和进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8811/11786634/c5ae48634fdc/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8811/11786634/09b9b333b537/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8811/11786634/a93722b9544c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8811/11786634/69a2dc21715e/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8811/11786634/13dae750e336/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8811/11786634/c5ae48634fdc/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8811/11786634/09b9b333b537/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8811/11786634/a93722b9544c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8811/11786634/69a2dc21715e/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8811/11786634/13dae750e336/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8811/11786634/c5ae48634fdc/gr5.jpg

相似文献

1
Prediction of angiogenesis suppression by myricetin from via inhibiting VEGFR2 signaling pathway using computer-aided analysis.通过计算机辅助分析预测杨梅素通过抑制VEGFR2信号通路抑制血管生成。
Heliyon. 2025 Jan 7;11(2):e41749. doi: 10.1016/j.heliyon.2025.e41749. eCollection 2025 Jan 30.
2
Pharmacological investigation of analgesic and antipyretic activities of methanol extract of the whole part of Aeginetia indica.镇痛和解热活性的药理学研究甲醇提取物的整个部分的 Aeginetia indica。
J Ethnopharmacol. 2021 May 10;271:113915. doi: 10.1016/j.jep.2021.113915. Epub 2021 Feb 7.
3
Cyperenoic acid, a sesquiterpene derivative from Croton crassifolius, inhibits tumor growth through anti-angiogenesis by attenuating VEGFR2 signal pathway in breast cancer.香附子烯酸是一种来自厚叶巴豆的倍半萜衍生物,它通过减弱乳腺癌中的VEGFR2信号通路,抑制血管生成,从而抑制肿瘤生长。
Phytomedicine. 2020 May 30;76:153253. doi: 10.1016/j.phymed.2020.153253.
4
Ethyl cinnamate suppresses tumor growth through anti-angiogenesis by attenuating VEGFR2 signal pathway in colorectal cancer.肉桂酸乙酯通过抑制 VEGFR2 信号通路抑制血管生成从而抑制结直肠癌细胞生长。
J Ethnopharmacol. 2024 May 23;326:117913. doi: 10.1016/j.jep.2024.117913. Epub 2024 Feb 14.
5
Computational Investigation of 1, 3, 4 Oxadiazole Derivatives as Lead Inhibitors of VEGFR 2 in Comparison with EGFR: Density Functional Theory, Molecular Docking and Molecular Dynamics Simulation Studies.基于密度泛函理论、分子对接和分子动力学模拟研究 1,3,4-噁二唑衍生物作为 VEGFR2 和 EGFR 抑制剂的先导化合物。
Biomolecules. 2022 Nov 1;12(11):1612. doi: 10.3390/biom12111612.
6
Myricetin Inhibits Breast Tumor Growth and Angiogenesis by Regulating VEGF/VEGFR2 and p38MAPK Signaling Pathways.杨梅素通过调控 VEGF/VEGFR2 和 p38MAPK 信号通路抑制乳腺癌生长和血管生成。
Anat Rec (Hoboken). 2019 Dec;302(12):2186-2192. doi: 10.1002/ar.24222. Epub 2019 Jul 17.
7
Novel angiogenesis inhibitory activity in cinnamon extract blocks VEGFR2 kinase and downstream signaling.肉桂提取物具有新型的血管生成抑制活性,可阻断 VEGFR2 激酶及其下游信号转导。
Carcinogenesis. 2010 Mar;31(3):481-8. doi: 10.1093/carcin/bgp292. Epub 2009 Dec 7.
8
Structure and activity relationship analysis of xanthones from mangosteen: Identifying garcinone E as a potent dual EGFR and VEGFR2 inhibitor.山竹中呫吨酮类化合物的结构与活性关系分析:确定藤黄酮E为一种有效的表皮生长因子受体(EGFR)和血管内皮生长因子受体2(VEGFR2)双重抑制剂。
Phytomedicine. 2024 Jan;122:155140. doi: 10.1016/j.phymed.2023.155140. Epub 2023 Oct 6.
9
Chemical Characterization, Evaluation, and Molecular Docking Analysis of Antiproliferative Compounds Isolated from the Bark of Miq.从 Miq. 的树皮中分离得到的具有抗增殖活性的化合物的化学特征、评价和分子对接分析
Anticancer Agents Med Chem. 2022;22(20):3416-3437. doi: 10.2174/1871520622666220204123348.
10
Rutacecarpine Inhibits Angiogenesis by Targeting the VEGFR2 and VEGFR2-Mediated Akt/mTOR/p70s6k Signaling Pathway.芸香卡品通过靶向 VEGFR2 及其介导的 Akt/mTOR/p70s6k 信号通路抑制血管生成。
Molecules. 2018 Aug 15;23(8):2047. doi: 10.3390/molecules23082047.

本文引用的文献

1
Renal cell carcinoma therapy: Current and new drug candidates.肾细胞癌治疗:现有和新型候选药物。
Drug Discov Today. 2022 Jan;27(1):304-314. doi: 10.1016/j.drudis.2021.07.009. Epub 2021 Jul 12.
2
Pharmacological investigation of analgesic and antipyretic activities of methanol extract of the whole part of Aeginetia indica.镇痛和解热活性的药理学研究甲醇提取物的整个部分的 Aeginetia indica。
J Ethnopharmacol. 2021 May 10;271:113915. doi: 10.1016/j.jep.2021.113915. Epub 2021 Feb 7.
3
Exploration of structural requirements for the inhibition of VEGFR-2 tyrosine kinase: Binding site analysis of type II, 'DFG-out' inhibitors.
探索 VEGFR-2 酪氨酸激酶抑制作用的结构要求:II 型,“DFG-out”抑制剂的结合位点分析。
J Biomol Struct Dyn. 2022 Aug;40(12):5712-5727. doi: 10.1080/07391102.2021.1872417. Epub 2021 Jan 18.
4
Antidiabetic and hepatoprotective potential of whole plant extract and isolated compounds of Aeginetia indica.白皮桑植物全株提取物及其单体成分的降血糖和保肝作用。
Biomed Pharmacother. 2020 Dec;132:110942. doi: 10.1016/j.biopha.2020.110942. Epub 2020 Nov 1.
5
Corrigendum: Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice.勘误:癌症治疗中的植物化学物质:从临床前研究到临床实践
Front Pharmacol. 2020 Feb 28;11:175. doi: 10.3389/fphar.2020.00175. eCollection 2020.
6
Application of computational methods for anticancer drug discovery, design, and optimization.计算方法在抗癌药物发现、设计和优化中的应用。
Bol Med Hosp Infant Mex. 2016 Nov-Dec;73(6):411-423. doi: 10.1016/j.bmhimx.2016.10.006. Epub 2016 Nov 30.
7
Aeginetia indica Decoction Inhibits Hepatitis C Virus Life Cycle.印度獐牙菜汤抑制丙型肝炎病毒生命周期。
Int J Mol Sci. 2018 Jan 9;19(1):208. doi: 10.3390/ijms19010208.
8
A novel synthetic small molecule YF-452 inhibits tumor growth through antiangiogenesis by suppressing VEGF receptor 2 signaling.一种新型合成小分子YF-452通过抑制血管内皮生长因子受体2信号通路的抗血管生成作用来抑制肿瘤生长。
Sci China Life Sci. 2017 Feb;60(2):202-214. doi: 10.1007/s11427-016-0369-6. Epub 2017 Feb 13.
9
A phase II study of tivozanib in patients with metastatic and nonresectable soft-tissue sarcomas.替沃扎尼用于转移性和不可切除软组织肉瘤患者的II期研究。
Ann Oncol. 2017 Jan 1;28(1):121-127. doi: 10.1093/annonc/mdw444.
10
Development and strategies of VEGFR-2/KDR inhibitors.VEGFR-2/KDR 抑制剂的研发与策略。
Future Med Chem. 2012 Sep;4(14):1839-52. doi: 10.4155/fmc.12.121.